Identification of a Risk Allele at SLC41A3 and a Protective Allele HLA-DPB1*02:01 Associated with Sarcopenia in Japanese
Authors:
- 18 March 2025
- journal article
- Published by S. Karger AG in Gerontology
- Vol. 71 (5) , 376-387
Abstract
Introduction: Age-related alterations in muscle tissue morphology and function, as well as chronic pro-inflammatory conditions, contribute to the development of sarcopenia. To elucidate the multidimensional pathogenesis of sarcopenia, we performed a comprehensive genetic analysis, including common variants, rare variants, and human leukemia antigen (HLA). Methods: A total of 129 older adults were analyzed using whole-genome sequencing (WGS), including 67 sarcopenia patients and 62 normal controls. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia 2019 consensus. WGS data and associated clinical data were obtained from the National Center for Geriatrics and Gerontology Biobank in Japan. We performed logistic regression adjusted for age, sex, and body mass index for common variant (minor allele frequency [MAF] ≧0.01), rare variant (MAF <0.01), and HLA analyses. For the functional analysis, we performed RNA interference using human myoblasts and estimated gene expressions (MYOG, MYMK, MYMG) by quantitative PCR. Results: Rare variant analysis identified five rare coding variants of genes – SLC41A3, SYNRG, CLUAP1, CCHCR1, and ALDH2 – expressed in skeletal muscle. Of these, a deleterious frameshift deletion in SLC41A3 was associated with the pathogenesis of sarcopenia (p = 0.0012, odds ratio [OR] = 11.52, 95% confidence interval [CI] = 2.62–50.69). This deletion significantly reduced expression of myogenin (MYOG), a factor involved in myoblast differentiation (p = 0.0094), but did not affect the fusion of myogenic cells. We also discovered a new protective allele, HLA-DPB1*02:01 associated with sarcopenia (OR = 0.17, 95% CI = 0.060–0.51, p = 0.0015), which has a high occurrence rate in the Northeast Asian population. Conclusion: Rare variant analysis identified a deleterious frameshift deletion in SLC41A3 as a risk factor for sarcopenia. Our findings suggest that the suppression of MYOG could play a role in myogenesis or muscle maintenance, although this mutation did not impact the terminal differentiation of human myoblasts. Additionally, HLA analysis revealed that HLA-DPB1*02:01 has a protective effect, especially in Northeast Asian populations. Our study enhances the understanding of the etiology of sarcopenia and provides new insights into the mechanisms of its pathogenesis.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Genome-wide association study reveals an association between the HLA-DPB1∗02:01:02 allele and wheat-dependent exercise-induced anaphylaxisThe American Journal of Human Genetics, 2021
- Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adultsJournal of Cachexia, Sarcopenia and Muscle, 2020
- Muscle‐restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down‐regulation of myogenin at the neuromuscular junctionJournal of Cachexia, Sarcopenia and Muscle, 2018
- The human protein atlas: A spatial map of the human proteomeProtein Science, 2017
- HLA‐HD: An accurate HLA typing algorithm for next‐generation sequencing dataHuman Mutation, 2017
- Biomarkers for physical frailty and sarcopenia: state of the science and future developmentsJournal of Cachexia, Sarcopenia and Muscle, 2015
- Solute carrier family SLC41: what do we really know about it?Wiley Interdisciplinary Reviews: Membrane Transport and Signaling, 2013
- Magnesium deficiency up‐regulates Myod expression in rat skeletal muscle and C2C12 myogenic cellsCell Biochemistry and Function, 2011
- Hand grip strength: A phenotype suitable for identifying genetic variants affecting mid‐ and late‐life physical functioningGenetic Epidemiology, 2002
- Myogenin, a factor regulating myogenesis, has a domain homologous to MyoDCell, 1989